Hester Biosciences Limited has informed the Exchange regarding Proceedings of undefined held on August 13, 2025. Further, the company has informed the Exchange regarding voting results along with copy of scrutinizers report together with copy of minutes.
HESTERBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Hester Biosciences held its 38th AGM on August 13, 2025 via video conferencing, running from 10:33 a.m. to 11:22 a.m. (about 49 minutes). All 6 resolutions were passed with overwhelming shareholder approval, ranging from 99.99% to 100% in favour. Key items included adoption of audited standalone and consolidated financial statements for FY ended 31 March 2025, declaration of a dividend on equity shares, re-appointment of Dr. Bhupendra Gandhi as director retiring by rotation, appointment of the secretarial auditor, and ratification of cost auditors' remuneration for FY 2025-26. Voting turnout was healthy at 58.46% of outstanding equity (49,73,432 shares), with 54 members attending via VC. Both the statutory and secretarial auditor reports contained no qualifications or adverse remarks.
Routine procedural filing confirming clean shareholder approval of all AGM agenda items, including the dividend. No negative surprises; unlikely to have any material impact on the stock price.